France intends to stay in the race for health data.
Its competitiveness on the global pharmaceutical scene depends on it.
Three heavyweights in the sector, the AstraZeneca laboratory, the digital subsidiary of La Poste, Docaposte, as well as the company Impact Healthcare, specializing in innovation consulting, are launching Agoria Santé, a platform for collecting and analyzing health data at service of better therapeutic management of patients.
Cyber attacks: why your health data is so fragile and coveted
The objective is to provide a legal, ethical and secure framework for healthcare players in order to enable them to go faster in research,”
explains Olivier Nataf, head of the French subsidiary of AstraZeneca.
The catalog of data and services offered is intended to grow over time.
Partnerships could be forged via this platform around common themes.
It is a project open to all health stakeholders.
Five labs could soon join Agoria Santé.
This article is for subscribers only.
You have 69% left to discover.
To cultivate your freedom is to cultivate your curiosity.
Continue reading your article for € 1 the first month
I ENJOY IT